Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal With Peptide...
We report a case of ceftriaxone-induced immune hemolytic anemia in a 10-year-old with chronic active Epstein-Barr virus disease and hemophagocytic...
Read MoreInhibition of Immune Complex Complement Activation And Neutrophil Extracellular...
Abstract: Two major aspects of systemic lupus erythematosus (SLE) pathogenesis that have yet to be targeted therapeutically are immune complex-initiated...
Read MorePeptide Inhibitor Of Complement C1 (PIC1) Demonstrates Antioxidant Activity...
Reactive oxygen species (ROS) are natural byproducts of oxidative respiration that are toxic to organs and tissues. To mitigate ROS...
Read MorePeptide Inhibitor Of Complement C1 (PIC1) Inhibits Growth Of...
Peptide Inhibitor of Complement C1 (PIC1) is a family of 15 amino acid peptides that inhibit complement activation via the...
Read MorePeptide Inhibitor Of Complement C1 Inhibits The Peroxidase Activity...
Hemoglobin is the natural carrier of oxygen in red blood cells (RBCs). While intracellular hemoglobin provides life-sustaining oxygen transport, extracellular...
Read MoreInhibition Of Myeloperoxidase Activity In Cystic Fibrosis Sputum By...
Myeloperoxidase is the major peroxidase enzyme in neutrophil granules and implicated in contributing to inflammatory lung damage in cystic fibrosis....
Read MoreComplement Activation And STAT4 Expression Are Associated With Early...
Diabetic non-healing wounds are a major clinical problem. The mechanisms leading to poor wound healing in diabetes are multifactorial but...
Read MoreDiscriminating The Hemolytic Risk Of Blood Type A Plasmas...
Diabetic non-healing wounds are a major clinical problem. The mechanisms leading to poor wound healing in diabetes are multifactorial but...
Read MorePeptide Inhibitor Of Complement C1 Modulates Acute Intravascular Hemolysis...
Acute hemolytic transfusion reactions have a broad clinical presentation from mild and transitory signs and symptoms to shock, disseminated intravascular...
Read More